Laboratoires Pierre Fabre announce that the Committee for Medicinal Products for Human Use (CHMP), the scientific advisory committee of the European Medicines Agency (EMEA), has issued a positive opinion supporting approval and is recommending to grant marketing authorisation for JAVLOR(R) as monotherapy in metastatic treatment of bladder cancer (advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinum-containing regimen). biotech investors
A revolutionary new protein stabilisation technique has been developed by scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) which could lead to 30 per cent more proteins being available as potential targets for drug development opening up exciting possibilities in drug discovery. biotech investors
It is now possible to engineer tiny containers the size of a virus to deliver drugs and other materials with almost 100 percent efficiency to targeted cells in the bloodstream. According to a new Cornell study, the technique could one day be used to deliver vaccines, drugs or genetic material to treat cancer and blood and immunological disorders. The research was published recently (June 25, 2009) online at the Web site of the journal Gene Therapy. biotech investors
If you have hay fever, headaches or a cold, it’s only a short way to the nearest chemist. The drugs, on the other hand, can take eight to ten years to develop. Until now animal experiments have been an essential step, yet they continue to raise ethical issues. “Our artificial organ systems are aimed at offering an alternative to animal experiments,” says Professor Heike Mertsching of the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart. biotech investors
Immuncor shares sink on FDA action (BLUD) : BioHealth Investor .Comments. Comments are closed. Subscribe to BioHealth Investor – Biotech and Medical Business Blog BioHealth Investor RSS Feed. Recent Posts. Immuncor shares sink on FDA action (BLUD) · Feds seize drugs from Caraco Labs plants (CPD) .
But never mind — Mr. Rosenwald is now a “prominent investor.” In fact, he is not just a “prominent investor”— he is one of America’s biggest biotech investors, if not the biggest biotech investor. D.H. Blair was known for investing in .Michael Milken, 60000 Deaths, and the Story of Dendreon (Chapter 3 .
Survey Says: Biotech Investors Cry Over Genentech (And More .BNET Pharma provides daily industry news coverage and insights for managers and executives about the major manufacturers of pharmaceuticals and medicine.
But never mind — Mr. Rosenwald is now a “prominent investor.” In fact, he is not just a “prominent investor”— he is one of America’s biggest biotech investors, if not the biggest biotech investor. D.H. Blair was known for investing in .Michael Milken, 60000 Deaths, and the Story of Dendreon (Chapter 3 .
